203 related articles for article (PubMed ID: 33259227)
1. Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings.
Ghazvinian R; Elf J; Löfvendahl S; Holst J; Gottsäter A
Clin Appl Thromb Hemost; 2020; 26():1076029620937352. PubMed ID: 33259227
[TBL] [Abstract][Full Text] [Related]
2. A cost-analysis model for anticoagulant treatment in the hospital setting.
Mody SH; Huynh L; Zhuo DY; Tran KN; Lefebvre P; Bookhart B
J Med Econ; 2014 Jul; 17(7):492-8. PubMed ID: 24773068
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism.
Ghazvinian R; Gottsäter A; Elf JL
J Thromb Thrombolysis; 2018 Feb; 45(2):319-324. PubMed ID: 29305675
[TBL] [Abstract][Full Text] [Related]
4. Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience.
Filopei J; Bondarsky EE; Ehrlich M; Islam M; Bajpayee G; Pang D; Shujaat A; Rowland J; Steiger DJ
J Thromb Thrombolysis; 2020 Aug; 50(2):399-407. PubMed ID: 31997255
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
[TBL] [Abstract][Full Text] [Related]
6. Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism.
Roy PM; Corsi DJ; Carrier M; Theogene A; de Wit C; Dennie C; Le Gal G; Delluc A; Moumneh T; Rodger M; Wells P; Gandara E
J Thromb Haemost; 2017 Apr; 15(4):685-694. PubMed ID: 28106343
[TBL] [Abstract][Full Text] [Related]
7. A pharmacoeconomic study of traditional anticoagulation versus direct oral anticoagulation for the treatment of venous thromboembolism in the emergency department.
Law S; Ghag D; Grafstein E; Stenstrom R; Harris D
CJEM; 2016 Sep; 18(5):340-8. PubMed ID: 27618975
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism.
Wolfe A; Phillips A; Tierney DM; Melamed R; Qadri G; Lillyblad M; Smith C; St Hill C; Stenzel AE; Beddow D; Kirven J; Kethireddy R; Patel L
Clin Appl Thromb Hemost; 2023; 29():10760296231156414. PubMed ID: 36890702
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
[TBL] [Abstract][Full Text] [Related]
10. Reducing the hospital burden associated with the treatment of pulmonary embolism.
Peacock WF; Singer AJ
J Thromb Haemost; 2019 May; 17(5):720-736. PubMed ID: 30851227
[TBL] [Abstract][Full Text] [Related]
11. Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience.
Paczyńska M; Kurnicka K; Lichodziejewska B; Goliszek S; Dzikowska-Diduch O; Sobieraj P; Burzyński Ł; Kostrubiec M; Pruszczyk P; Ciurzyński M
Kardiol Pol; 2016; 74(7):650-6. PubMed ID: 26779849
[TBL] [Abstract][Full Text] [Related]
12. Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism.
Wang L; Baser O; Wells P; Peacock WF; Coleman CI; Fermann GJ; Schein J; Crivera C
Clin Ther; 2017 Jul; 39(7):1426-1436.e2. PubMed ID: 28652016
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.
Coleman CI; Baugh C; Crivera C; Milentijevic D; Wang SW; Lu L; Nelson WW
J Med Econ; 2017 Feb; 20(2):200-203. PubMed ID: 27780397
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism.
Zondag W; den Exter PL; Crobach MJ; Dolsma A; Donker ML; Eijsvogel M; Faber LM; Hofstee HM; Kaasjager KA; Kruip MJ; Labots G; Melissant CF; Sikkens MS; Huisman MV;
Thromb Haemost; 2013 Jan; 109(1):47-52. PubMed ID: 23138355
[TBL] [Abstract][Full Text] [Related]
15. The value of sPESI for risk stratification in patients with pulmonary embolism.
Wells P; Peacock WF; Fermann GJ; Coleman CI; Wang L; Baser O; Schein J; Crivera C
J Thromb Thrombolysis; 2019 Jul; 48(1):149-157. PubMed ID: 30729377
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.
Deitelzweig SB; Lovelace B; Christoph M; Lingohr-Smith M; Lin J; Fermann GJ
Adv Ther; 2020 Sep; 37(9):3942-3953. PubMed ID: 32699994
[TBL] [Abstract][Full Text] [Related]
17. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
18. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
Maughan BC; Frueh L; McDonagh MS; Casciere B; Kline JA
Acad Emerg Med; 2021 Feb; 28(2):226-239. PubMed ID: 32779290
[TBL] [Abstract][Full Text] [Related]
19. Value of Cardiac Troponin and sPESI in Treatment of Pulmonary Thromboembolism at Outpatient Setting.
Ozsu S; Bektas H; Abul Y; Ozlu T; Örem A
Lung; 2015 Aug; 193(4):559-65. PubMed ID: 25840529
[TBL] [Abstract][Full Text] [Related]
20. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
